Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹107.27 Cr |
| Reserved for Market Maker | ₹5.39 Cr |
| Net Issue Size | ₹107.27 Cr |
| Fresh Issue | ₹65.34 Cr |
| Offer for Sale | ₹36.54 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹151.00-159.00 per share |
| Discount | Employee: 15.00 |
| NSE Code | CHANDAN |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Unistone Capital Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 800 shares and in multiples thereof
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.
As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand.
As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes
The radiology facilities have eleven CT scanners and four MRI machines.
As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals.
Products and services:
The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up of a new Flagship diagnostic centre in Jankipuram, Lucknow, Uttar Pradesh. | 32.82 |
| 2 | Setting up of a new Central Reference laboratory at Ayodhya, Uttar Pradesh. | 7.10 |
| 3 | Setting up of a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh. | 7.10 |
| 4 | General Corporate Purposes | 16.72 |
| 5 | Issue Expenses | 10.14 |
| Total | 73.89 |
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 170.06 | 128.86 | 97.83 | 81.23 |
| Total Income | 167.99 | 177.96 | 137.03 | 119.92 |
| Profit After Tax | 17.42 | 16.36 | 3.59 | -1.09 |
| NET Worth | 41.09 | 27.30 | 23.93 | |
| Reserves and Surplus | 34.31 | 21.16 | 7.37 | 4.00 |
| Total Borrowing | 51.92 | 42.01 | 21.36 | 16.58 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 47.50% |
| ROCE | 35.20% |
| Debt / Equity | 1.02% |
| RoNW | 39.54% |
| PAT Margin | 9.26% |
| Price to Book Value | 7.73 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 8.18 | 9.50 |
| P/E (x) | 19.44 | 16.74 |
| Promoter Holding | 69.96% | 49.2% |
| Market Cap | ₹388.79 Cr. | |
